Inspira Technologies Oxy B.H.N. Ltd (IINN)

$0.89 -0.04 (-4.01%)
Market Cap 12.12M
Revenue (ttm) 0.00
Net Income (ttm) -11.05M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 8.41
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 99,800
Avg Vol 167,442
Day's Range N/A - N/A
Shares Out 12.62M
Stochastic %K 18%
Beta 2.26
Analysts Sell
Price Target $5.00

Company Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacturing, and marketing of proprietary life support technologies for the treatment of acute respiratory failure in Israel. It offers INSPIRA ART100, a life support system used in procedures requiring cardiopulmonary bypass for six hours or less. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. Inspira...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 4 623 0333
Address:
2 Ha-Tidhar St., Ra'anana, Israel
Clemsondoc
Clemsondoc Jan. 14 at 11:27 PM
$IINN how long does YA have to hold shares before they can sell
0 · Reply
PARABOLICMAMA
PARABOLICMAMA Jan. 14 at 10:25 PM
$IINN LFGGGGGGGG to $10 with FDA approval soon!!!!!!
0 · Reply
jedledbetter
jedledbetter Jan. 14 at 10:18 PM
$IINN come on YA pump it!
0 · Reply
THE_Perfusionist
THE_Perfusionist Jan. 14 at 8:35 PM
$IINN I’m feeling Pennies…
1 · Reply
OGLUCIDBULL
OGLUCIDBULL Jan. 14 at 7:54 PM
$IINN the bad boy is selling infinite cheat shares into the ticker. I Wana cheat too!
0 · Reply
Clemsondoc
Clemsondoc Jan. 14 at 7:53 PM
$IINN brutal. There’s no benefit for them to have people hold or buy shares right now
1 · Reply
jedledbetter
jedledbetter Jan. 14 at 6:06 PM
$IINN thisthi
0 · Reply
Laurapicksright
Laurapicksright Jan. 14 at 5:53 PM
$IINN looks like a good entry point for me!! This can go big off $GELS $IVP 😍😍😍
1 · Reply
Clemsondoc
Clemsondoc Jan. 14 at 5:09 PM
$IINN I wrote the company asked for an answer or a few minutes of their time. My question to them (so maybe someone here can answer) is how is the stock price going to rise if profits from products are paid out to the CVRs? What can move the stock price? How are you going to avoid getting booted from the Nasdaq? Did YA know about this merger? Why should I buy more shares?
1 · Reply
2ps
2ps Jan. 14 at 3:57 PM
$IINN lots of interesting stuff in this article: 1- An existing "reimbursement code" is already in place for the intended clinical use, providing a defined path to reimbursement if regulatory clearance is obtained. 2- Viewed in isolation, Inspira’s activities — life-support systems, continuous blood monitoring, and now diagnostics - could appear loosely connected. Taken together, however, they suggest a company organizing its technology around a consistent theme: real-time blood analysis.
0 · Reply
Latest News on IINN
CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Jan 5, 2026, 10:46 AM EST - 9 days ago

CORRECTION – Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Investment of $15 Million into Inspira at $180 Million Valuation

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Jan 5, 2026, 9:30 AM EST - 9 days ago

Inspira Signs Term Sheet for Acquisition of Advanced Liquid Biopsy Cancer Diagnostics Technology and Concurrent $15 Million Investment at $180 Million Valuation

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Dec 23, 2025, 8:30 AM EST - 22 days ago

Inspira Technologies Reaffirms $49.5 Million in Binding Purchase Orders and Aligns Execution with 2026 Regulatory and Deployment Milestones

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Dec 15, 2025, 8:30 AM EST - 4 weeks ago

Inspira Announces $1.8 Million Registered Direct Offering Priced At-The-Market and Additional Equity Financing Agreement to Support Ongoing Commercial Execution

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Dec 3, 2025, 8:43 AM EST - 6 weeks ago

Inspira Technologies Announces Strategic Leap in Lab Capabilities – Accelerating Next-Generation Diagnostics and Blood Technology

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Nov 13, 2025, 9:00 AM EST - 2 months ago

Inspira Completes Clinical Study for HYLA™ Blood Sensor - Ahead of Regulatory Submission

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Nov 6, 2025, 9:10 AM EST - 2 months ago

Inspira Technologies Nears Final Regulatory Clearance for the ART100 in the UAE, Accelerating Gulf Region Expansion

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Oct 22, 2025, 8:30 AM EDT - 3 months ago

Inspira and Bites Form Strategic Alliance to Embed AI as a Core Standard Across Inspira's Global Ecosystem

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Oct 21, 2025, 9:05 AM EDT - 3 months ago

Inspira Appoints Former Johnson & Johnson Executive as VP of Global Sales and New Board Member from a Leading International Investment Firm

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Oct 1, 2025, 8:00 AM EDT - 3 months ago

Inspira Technologies Reports First Half 2025 Financial Results and Issues Business Update

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Sep 11, 2025, 9:30 AM EDT - 4 months ago

Inspira Announces 97.3% Accuracy Results for HYLA™ Blood Sensor, Advancing Toward FDA Submission for Clearance

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Aug 22, 2025, 8:45 AM EDT - 5 months ago

Inspira Receives U.S. Patent Approval for the ART500 Core Technology, Key Patent Positions the Company to Dominate $20 Billion Estimated Market

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Aug 7, 2025, 9:44 AM EDT - 5 months ago

Inspira Clarifies Routine Nature of Registration Statement on Form F-3 Filing Performed Every Three Years

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Jul 31, 2025, 9:15 AM EDT - 5 months ago

Inspira Activates U.S. Based Consulting Firm to Execute Transformational Initiatives

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Jul 18, 2025, 8:10 AM EDT - 6 months ago

Inspira Regains Compliance with Nasdaq Minimum Bid Price Requirement

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Jul 10, 2025, 9:25 AM EDT - 6 months ago

Inspira Achieves All Key Objectives in Previously Announced Government Talks, Forging a Pathway to National Adoption and Global Scale-Up of the ART100

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Jul 7, 2025, 8:50 AM EDT - 6 months ago

Inspira in High-Level Government Talks to Advance National Integration of the ART100 and Establish a Global Distribution Framework

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Jul 2, 2025, 9:23 AM EDT - 7 months ago

Inspira Technologies Secures $22.5 Million Purchase Order, Launches Full Revenue Execution Phase

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

Jun 11, 2025, 9:10 AM EDT - 7 months ago

Inspira's ART100 in Use at Tier-1 U.S. Hospitals, Generating Strong Clinical Interest and Accelerating Sales Discussions

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Jun 5, 2025, 11:15 AM EDT - 7 months ago

CORRECTION - Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Jun 5, 2025, 9:15 AM EDT - 7 months ago

Inspira Scales Up ART100 Production Capabilities Amid Advanced Negotiation with European Government Authority

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

May 29, 2025, 9:15 AM EDT - 8 months ago

Inspira Technologies Initiates Global Commercial Rollout of FDA-Cleared ART100 System

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

May 7, 2025, 8:45 AM EDT - 9 months ago

INSPIRA ART100 System Approved by Israel's Largest Healthcare Provider for Use in Organ Transplant Patients

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Apr 23, 2025, 8:00 AM EDT - 9 months ago

Inspira Achieves above 99% Gas Exchange Efficiency in VORTX™ Technology In-Vivo Animal Testing

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Apr 15, 2025, 9:15 AM EDT - 9 months ago

Inspira Technologies Generates First Revenues from Deployment of INSPIRA ART100 Systems

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Mar 25, 2025, 8:30 AM EDT - 10 months ago

Inspira Technologies Announces Successful Installation of INSPIRA ART100 Systems in Premier U.S. Hospital

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

Mar 19, 2025, 8:30 AM EDT - 10 months ago

Inspira Technologies' Innovative Life-Support System to be Showcased at AmSECT 63rd International Conference 2025 in San Diego

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Mar 18, 2025, 1:17 PM EDT - 10 months ago

PESG Report: Inspira Technologies' AI-Powered Respiratory System Could Revolutionize Care for 20 Million Annual ICU Patients in Combined $25+ Billion Market

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Mar 14, 2025, 7:00 AM EDT - 10 months ago

Inspira Technologies Releases CEO Update: Major Milestones Signal Next-Level Respiratory Care

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Mar 13, 2025, 4:30 PM EDT - 10 months ago

Inspira Technologies Receives Nasdaq Notification Regarding Minimum Bid Requirement

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

Mar 11, 2025, 8:30 AM EDT - 11 months ago

Inspira Technologies Reports Full Year 2024 Financial Results and Provides Business Updates

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Mar 5, 2025, 8:46 AM EST - 11 months ago

PESG Report: Inspira Technologies Breaks new Ground with Positive Clinical Data for AI-Powered Blood Sensor Exceeding Expectations

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Mar 4, 2025, 8:30 AM EST - 11 months ago

Inspira Technologies Announces Positive Results from Clinical Study of HYLA Blood Sensor, Achieving 96% Accuracy

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

Feb 11, 2025, 7:00 AM EST - 1 year ago

Inspira Achieves Positive Results of Above 95% For Preventing Bloodstream Infections

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Feb 6, 2025, 8:27 AM EST - 1 year ago

PESG Report: Inspira Technologies Strengthens its AI-Powered Blood Sensor with new Capabilities, Intends to Share Clinical Findings Soon

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Feb 5, 2025, 8:30 AM EST - 1 year ago

Inspira Technologies Integrates New Oxygenation Indicator into AI-Powered HYLA Blood Sensor

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Jan 27, 2025, 8:30 AM EST - 1 year ago

Inspira™ Introduces Advanced Features for INSPIRA™ ART100, Further Amplifying User and System Support

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Jan 22, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Prepares its First Life-Support Systems for Deployment at a Leading U.S. Hospital

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Jan 21, 2025, 8:30 AM EST - 1 year ago

Inspira™ Announces the Appointment of Tal Parnes as the New Chairman of the Board, Bringing Vast Experience in the Medical Technology and Pharmaceutical Sectors

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Jan 17, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Collaborates With Zriha Medical To Launch Cutting-Edge Production Line

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Jan 14, 2025, 8:30 AM EST - 1 year ago

Inspira™ Technologies Unveils Modular Configuration for Revolutionary VORTX™ Blood Oxygenation Delivery Technology

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Jan 10, 2025, 6:15 AM EST - 1 year ago

Inspira™ Preparing Production in Response to Spread of Respiratory Virus in China

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Jan 7, 2025, 8:15 AM EST - 1 year ago

Inspira™ Technologies Flagship Technology to be Showcased at Arab Health Expo 2025 in Dubai

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

Dec 27, 2024, 10:09 AM EST - 1 year ago

Inspira™ Announces Pricing of $3.2M Private Placement by New and Existing Investors of the Company

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

Dec 16, 2024, 8:30 AM EST - 1 year ago

Inspira™ Technologies Delivers Systems to Leading Distributor for U.S. Deployment

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

Dec 10, 2024, 8:00 AM EST - 1 year ago

Inspira™ Expands HYLA™ Blood Sensor Technology into Personalized Blood Lab Testing for Rapid Detection of Serious Medical Conditions

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

Dec 4, 2024, 7:00 AM EST - 1 year ago

Inspira™ Collaborates with New York's Westchester Medical Center to Evaluate the INSPIRA™ ART100 Functionality and Performance in Clinical Scenarios

Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Nov 8, 2024, 9:11 AM EST - 1 year ago

Join Inspira™ Technologies' Live Investor Webinar and Q&A Session on November 11

Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100

Oct 24, 2024, 8:30 AM EDT - 1 year ago

Inspira™ Announces Establishment of Distribution Facility to Support U.S. Deployment of INSPIRA™ ART100

Clemsondoc
Clemsondoc Jan. 14 at 11:27 PM
$IINN how long does YA have to hold shares before they can sell
0 · Reply
PARABOLICMAMA
PARABOLICMAMA Jan. 14 at 10:25 PM
$IINN LFGGGGGGGG to $10 with FDA approval soon!!!!!!
0 · Reply
jedledbetter
jedledbetter Jan. 14 at 10:18 PM
$IINN come on YA pump it!
0 · Reply
THE_Perfusionist
THE_Perfusionist Jan. 14 at 8:35 PM
$IINN I’m feeling Pennies…
1 · Reply
OGLUCIDBULL
OGLUCIDBULL Jan. 14 at 7:54 PM
$IINN the bad boy is selling infinite cheat shares into the ticker. I Wana cheat too!
0 · Reply
Clemsondoc
Clemsondoc Jan. 14 at 7:53 PM
$IINN brutal. There’s no benefit for them to have people hold or buy shares right now
1 · Reply
jedledbetter
jedledbetter Jan. 14 at 6:06 PM
$IINN thisthi
0 · Reply
Laurapicksright
Laurapicksright Jan. 14 at 5:53 PM
$IINN looks like a good entry point for me!! This can go big off $GELS $IVP 😍😍😍
1 · Reply
Clemsondoc
Clemsondoc Jan. 14 at 5:09 PM
$IINN I wrote the company asked for an answer or a few minutes of their time. My question to them (so maybe someone here can answer) is how is the stock price going to rise if profits from products are paid out to the CVRs? What can move the stock price? How are you going to avoid getting booted from the Nasdaq? Did YA know about this merger? Why should I buy more shares?
1 · Reply
2ps
2ps Jan. 14 at 3:57 PM
$IINN lots of interesting stuff in this article: 1- An existing "reimbursement code" is already in place for the intended clinical use, providing a defined path to reimbursement if regulatory clearance is obtained. 2- Viewed in isolation, Inspira’s activities — life-support systems, continuous blood monitoring, and now diagnostics - could appear loosely connected. Taken together, however, they suggest a company organizing its technology around a consistent theme: real-time blood analysis.
0 · Reply
WallStWireAds
WallStWireAds Jan. 14 at 2:52 PM
$IINN https://www.bioreview.com/inspiras-recent-moves-signal-a-a-broader-play-around-real-time-blood-intelligence/
0 · Reply
WallStWireAds
WallStWireAds Jan. 14 at 2:41 PM
$IINN https://www.bioreview.com/hypothalamic-obesity-is-emerging-as-the-next-frontier-in-obesity-drug-development-and-palatin-is-worth-watching/
0 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 14 at 2:12 PM
$IINN what if there's already a buyer for all the legacy stuff? and this merger is designed to keep the company alive with a new direction? Just spit ballin here
1 · Reply
Clemsondoc
Clemsondoc Jan. 14 at 8:25 AM
$IINN if CVR is issues on shares prior to today why wouldn’t I sell now. Wait for non compliance notice and buy back at an even lower price?
1 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 14 at 12:10 AM
$IINN im lost, there's this company Angle burried down in the Denovo information that fits the bill but not seeing how the valuation works
0 · Reply
Clemsondoc
Clemsondoc Jan. 13 at 11:26 PM
$IINN 8 days company leaders if your listening. 8 days to close above $1.
0 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 13 at 10:34 PM
$IINN it does appear to be a product sold by Bio View, not the Ca company, jmo
1 · Reply
THE_Perfusionist
THE_Perfusionist Jan. 13 at 9:29 PM
$IINN Clueless.
2 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 13 at 7:38 PM
$IINN need a proper pr
0 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 13 at 7:33 PM
$IINN if target is Denova they are located in San Diego, Ca, USA
1 · Reply
CatalinaWineMix3r
CatalinaWineMix3r Jan. 13 at 7:15 PM
$IINN if there acquiring Denova im stoked Denovo is a Series D company with multiple Phase 3 assets. Total funding raised: $172M–$184M. Companies at this stage typically carry valuations in the $300M–$600M range, but this varies widely based on clinical data, IP, and partnerships.
1 · Reply
2ps
2ps Jan. 13 at 6:58 PM
$IINN this is my understanding of this deal
2 · Reply